Research map: Modern Management of Neurogenic Bladder

Back to the article

Papers in this map

  1. National population‐based estimates for major birth defects, 2010–2014 · Cara T. Mai · 2019 · 980 citations · Cited by this paper
  2. Pediatric to Adult Transition of Care in Inflammatory Bowel Disease: Keeping Patients on Track · 2025 · Related
  3. Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder · Paul Abrams · 2006 · 641 citations · Cited by this paper
  4. Bridging the Gaps to Pediatric Emergency Care Providers in Low-Resource Settings: Challenges and Pathways to Progress · 2025 · Related
  5. Clinical Practice Guideline for the Management of Asymptomatic Bacteriuria: 2019 Update by the Infectious Diseases Society of America · Lindsay E. Nicolle · 2018 · 556 citations · Cited by this paper
  6. Posterior Urethral Valves: Overview of Urologic Management from the Antenatal Period to Adulthood · 2024 · Related
  7. Drugs with anticholinergic effects and cognitive impairment, falls and all‐cause mortality in older adults: A systematic review and meta‐analysis · Kimberley Ruxton · 2015 · 374 citations · Cited by this paper
  8. Male Fertility Preservation in Children and Adolescents with Cancer · 2026 · Related
  9. The AUA/SUFU Guideline on Adult Neurogenic Lower Urinary Tract Dysfunction: Diagnosis and Evaluation · David A. Ginsberg · 2021 · 225 citations · Cited by this paper
  10. Recent Advances in the Management of Bronchopulmonary Dysplasia · 2025 · Related
  11. Treatment of the neurogenic bladder in spina bifida · Tom P.V.M. de Jong · 2008 · 208 citations · Cited by this paper
  12. What Is the Role of Antibiotic Stewardship in the NICU? · 2025 · Related
  13. IMPROVED BLADDER FUNCTION AFTER PROPHYLACTIC TREATMENT OF THE HIGH RISK NEUROGENIC BLADDER IN NEWBORNS WITH MYELOMENINGOCELE · Martin A. Kaefer · 1999 · 180 citations · Cited by this paper
  14. Pediatric MASLD: The New Era Practical Approach to Assessment and Treatment of Pediatric MASLD with Emphasis on Risk Factors and Obesity Medications · 2025 · Related
  15. EAU/ESPU guidelines on the management of neurogenic bladder in children and adolescent part I diagnostics and conservative treatment · Raimund Stein · 2019 · 180 citations · Cited by this paper
  16. Pediatric Irritable Bowel Syndrome: Current Understanding and Future Directions · 2025 · Related
  17. Neurogenic Bladder: Epidemiology, Diagnosis, and Management · Jalesh N. Panicker · 2020 · 175 citations · Cited by this paper
  18. Fluid and Electrolyte Management of the Neonate · 2026 · Related
  19. Update on Urological Management of Spina Bifida from Prenatal Diagnosis to Adulthood · Devon C. Snow-Lisy · 2015 · 172 citations · Cited by this paper
  20. A Review of the Long-term Outcomes of Incontinent Diversion in the Pediatric Neurogenic Bladder · 2025 · Related
  21. Health care expenditures of children and adults with spina bifida in a privately insured U.S. population · Lijing Ouyang · 2007 · 165 citations · Cited by this paper
  22. The neurogenic bladder: medical treatment · Carla Verpoorten · 2007 · 162 citations · Cited by this paper
  23. Transition Care: Future Directions in Education, Health Policy, and Outcomes Research · Niraj Kumar Sharma · 2014 · 158 citations · Cited by this paper
  24. The AUA/SUFU Guideline on Adult Neurogenic Lower Urinary Tract Dysfunction: Treatment and Follow-up · David A. Ginsberg · 2021 · 158 citations · Cited by this paper
  25. Neurogenic bladder: etiology and assessment · Stuart B. Bauer · 2008 · 157 citations · Cited by this paper
  26. Activation of Muscarinic M1 Acetylcholine Receptors Induces Long-Term Potentiation in the Hippocampus · Siobhan H. Dennis · 2015 · 150 citations · Cited by this paper
  27. Botulinum-A Toxin Detrusor Injection as a Novel Approach in the Treatment of Bladder Spasticity in Children with Neurogenic Bladder · Heinrich Schulte‐Baukloh · 2003 · 149 citations · Cited by this paper
  28. The National Spina Bifida Patient Registry: Profile of a Large Cohort of Participants from the First 10 Clinics · Kathleen J. Sawin · 2014 · 147 citations · Cited by this paper
  29. INTRAVESICAL OXYBUTYNIN FOR NEUROGENIC BLADDER DYSFUNCTION: LESS SYSTEMIC SIDE EFFECTS DUE TO REDUCED FIRST PASS METABOLISM · Gunnar Buyse · 1998 · 143 citations · Cited by this paper
  30. Anticholinergic drugs and incident dementia, mild cognitive impairment and cognitive decline: a meta-analysis · Nina T Pieper · 2020 · 139 citations · Cited by this paper
  31. Neurogenic Bladder Dysfunction Due to Myelomeningocele: Neonatal Versus Childhood Treatment · Hsi‐Yang Wu · 1997 · 130 citations · Cited by this paper
  32. International children's continence society's recommendations for initial diagnostic evaluation and follow‐up in congenital neuropathic bladder and bowel dysfunction in children · Stuart B. Bauer · 2012 · 125 citations · Cited by this paper
  33. Design and Methodological Considerations of the Centers for Disease Control and Prevention Urologic and Renal Protocol for the Newborn and Young Child with Spina Bifida · Jonathan C. Routh · 2016 · 120 citations · Cited by this paper
  34. Prevention of chronic kidney disease in spina bifida · Guido Filler · 2011 · 117 citations · Cited by this paper
  35. In vitro and in vivo tissue selectivity profile of solifenacin succinate (YM905) for urinary bladder over salivary gland in rats · Akiyoshi Ohtake · 2004 · 117 citations · Cited by this paper
  36. Blood–Brain Barrier Permeation and Efflux Exclusion of Anticholinergics Used in the Treatment of Overactive Bladder · Michael B. Chancellor · 2012 · 104 citations · Cited by this paper
  37. Contemporary Epidemiological Trends in Complex Congenital Genitourinary Anomalies · Jessica C. Lloyd · 2013 · 103 citations · Cited by this paper
  38. Long-Term Metabolic Effects of Urinary Diversion: A Comparison of Myelomeningocele Patients Managed by Clean Intermittent Catheterization and Urinary Diversion · Michael O. Koch · 1992 · 101 citations · Cited by this paper
  39. Adverse events after botulinum A toxin injection for neurogenic voiding disorders · Kevin de Laet · 2005 · 98 citations · Cited by this paper

Source: OpenAlex (CC0)